The Children's Hospital Westmead, Corner Hawkesbury Road and Hainsworth St, Westmead, NSW, 2145, Australia.
BMC Pediatr. 2023 Mar 14;23(1):118. doi: 10.1186/s12887-023-03915-4.
Spinal muscular atrophy (SMA) is an autosomal recessive condition affecting lower motor neurons causing progressive muscle atrophy. Anorexia nervosa (AN) is a psychiatric disorder characterised by intense fear of weight gain, restriction of energy intake, and preoccupation with body weight and shape. Low weight, gastrointestinal dysmotility, and respiratory infections are common in SMA but may mask AN. No paediatric cases of AN in SMA have been reported to date.
A 14-year-old female with SMA2 presented with 12 months of declining body weight to a nadir of 24.8 kg (BMI 11). This was initially attributed to medical complications including pneumonia and gastroenteritis, and chronic gut dysmotility associated with SMA. Despite almost 2 years of dietetic input and nutritional supplementation due to the weight plateauing from age 11, no significant restoration or gain was achieved. The Eating Disorder Examination-Questionnaire (EDE-Q) indicated a possible eating disorder and psychiatric evaluation confirmed AN. Initial management prioritised close medical monitoring and outpatient weight restoration on an oral meal plan. Skin fold anthropometric measurement was conducted to determine a minimum healthy weight. Individual psychological therapy and family sessions were undertaken. The patient developed major depression and a brief relapse with weight loss to 28 kg. Since then, the patient has maintained a weight of around 35 kg with stable mood.
Low body weight, feeding issues, gastrointestinal dysmotility, and respiratory infections are common in SMA and diagnostic overshadowing can lead to delayed recognition of anorexia nervosa. Change to growth trajectory and prolonged weight loss should prompt consideration of comorbid psychiatric issues. Screening measures such as the EDE-Q and DASS may be helpful in this population. Close liaison between the neurogenetics and psychiatry teams is helpful. Skin fold anthropometry can assist in identifying a minimum healthy weight range.
脊髓性肌萎缩症(SMA)是一种常染色体隐性疾病,影响下运动神经元,导致进行性肌肉萎缩。神经性厌食症(AN)是一种以强烈害怕体重增加、限制能量摄入、对体重和体型过分关注为特征的精神障碍。低体重、胃肠动力障碍和呼吸道感染在 SMA 中很常见,但可能掩盖 AN。迄今为止,尚未有 SMA 合并 AN 的儿科病例报告。
一名 14 岁女性 SMA2 患者,体重下降 12 个月,体重降至最低点 24.8kg(BMI 11)。最初归因于包括肺炎和胃肠炎在内的医疗并发症,以及与 SMA 相关的慢性肠道动力障碍。尽管由于 11 岁时体重停滞不前,近 2 年来一直接受饮食干预和营养补充,但体重没有明显恢复或增加。饮食障碍检查问卷(EDE-Q)表明可能存在饮食障碍,精神科评估证实为 AN。初始治疗重点是密切的医疗监测和门诊口服饮食计划体重恢复。进行体脂测量以确定最低健康体重。进行了个体心理治疗和家庭会议。患者发展为重度抑郁症,并短暂复发,体重降至 28kg。从那时起,患者的体重一直保持在 35kg 左右,情绪稳定。
低体重、喂养问题、胃肠动力障碍和呼吸道感染在 SMA 中很常见,诊断性掩盖可能导致厌食症的识别延迟。生长轨迹的改变和长期体重减轻应促使考虑合并的精神问题。EDE-Q 和 DASS 等筛查措施可能对此人群有帮助。神经遗传学和精神病学团队之间的密切联系很有帮助。体脂测量有助于确定最低健康体重范围。